Acetic Acid

Acetic Acid

SCHEMBL869818

CC(=O)O.CCC1(C)CCOO1

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
FFAR3 O14843 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11373991 0.72 ACHE (0.31)
Acetic Acid SCHEMBL869816 0.67 FFAR3 (0.35) FFAR3
Acetic Acid SCHEMBL28667404 0.65 KDM4E (0.33) KDM4EMAPTAPOBEC3G
Acetic Acid SCHEMBL8158174 0.64 FFAR3 (0.58) FFAR3
SCHEMBL11457277 0.61
SCHEMBL12011137 0.60
SCHEMBL78830 0.59
SCHEMBL25215916 0.58
Acetic Acid SCHEMBL1674890 0.58 FFAR3 (0.58) KDM4EFFAR3
Acetic Acid SCHEMBL4305539 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100209374-A1 Multi-Phase Personal Care Composition Comprising a Stabilizing Perfume Composition WEI KARL SHIQING 2010-08-19 US claimed
US-7700528-B2 Multi-phase personal care composition comprising a stabilizing perfume composition THE PROCTER & GAMBLE COMPANY (US) 2010-04-20 US claimed
EP-1942861-A2 MULTI-PHASE PERSONAL CARE COMPOSITION COMPRISING A STABILIZING PERFUME COMPOSITION The Procter and Gamble Company (US) 2008-07-16 EP claimed
US-20070135319-A1 Multi-phase personal care composition comprising a stabilizing perfume composition PROCTER & GAMBLE COMPANY, THE 2007-06-14 US claimed
WO-2007052224-A2 MULTI-PHASE PERSONAL CARE COMPOSITION COMPRISING A STABILIZING PERFUME COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2007-05-10 WO claimed
US-20070071780-A1 Personal care composition comprising a perfume booster accord PROCTER & GAMBLE COMPANY, THE 2007-03-29 US claimed
US-11896702-B2 Fragrance-enhancing compositions ALMENDRA PTE LTD. (SG) 2024-02-13 US disclosed
EP-4255384-A1 AQUEOUS HAIR CONDITIONER COMPOSITIONS CONTAINING SOLUBILIZED ANTI-DANDRUFF ACTIVES The Procter & Gamble Company (US) 2023-10-11 EP disclosed
US-20230303953-A1 CLEANING COMPOSITIONS AND USES THEREOF HENKEL AG & CO. KGAA (DE) 2023-09-28 US disclosed
CN-116568266-A Aqueous hair conditioner composition containing dissolved anti-dandruff active 宝洁公司 2023-08-08 CN disclosed
US-11672748-B2 Aqueous hair conditioner compositions containing solubilized anti-dandruff actives THE PROCTER & GAMBLE COMPANY (US) 2023-06-13 US disclosed
EP-4179054-A1 CLEANING COMPOSITIONS AND USES THEREOF Henkel AG & Co. KGaA (DE) 2023-05-17 EP disclosed
US-20220411716-A1 Consumer Products with Improved Aesthetics INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2022-12-29 US disclosed
EP-1707185-A1 Solvent materials and methods for preparing fragrance compositions INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) 2006-10-04 EP disclosed
EP-1706532-A1 FABRIC ARTICLE TREATING DEVICE AND SYSTEM WITH SUGGESTIVE SCENT The Procter and Gamble Company (US) 2006-10-04 EP disclosed
EP-1633845-A2 VOLATILE MATERIAL DELIVERY METHOD The Procter & Gamble Company (US) 2006-03-15 EP disclosed
WO-2005073454-A1 FABRIC ARTICLE TREATING DEVICE AND SYSTEM WITH SUGGESTIVE SCENT THE PROCTER & GAMBLE COMPANY (US) 2005-08-11 WO disclosed
US-20050091879-A1 Volatile material delivery method THE PROCTER & GAMBLE COMPANY 2005-05-05 US disclosed
US-20050076533-A1 Fabric article treating device and system with suggestive scent PROCTER & GAMBLE COMPANY, THE 2005-04-14 US disclosed
WO-2004094580-A2 VOLATILE MATERIAL DELIVERY METHOD THE PROCTER & GAMBLE COMPANY (US) 2004-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135319-A1 Multi-phase personal care composition comprising a stabilizing perfume composition CUTA, PARG, POLG KDM4E 4592/4885MAPT 2572/4885APOBEC3G 679/4885
US-11672748-B2 Aqueous hair conditioner compositions containing solubilized anti-dandruff actives POLR1C, NACA, PIK3C3 KDM4E 2735/4885MAPT 860/4885APOBEC3G 2987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.